Compliance Rate
Compliance Rate
100.0%
Compliant submissions
1
Incompliant submissions
0
Total trials
1
My Organizations' Clinical Trials
Showing 1175 of 1329 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/30/05
End: 08/31/06
Due: 08/31/07
Phase: N/A
Priority: Normal
Start: 09/30/15
End: 02/12/20
Due: 02/12/21
Phase: N/A
Priority: Normal
Start: 10/31/18
End: 06/30/24
Due: 06/30/25
Phase: N/A
Priority: Normal
Start: 10/31/11
End: 12/31/14
Due: 12/31/15
BYL719 + T-DM1 in HER2(+) Metastatic Breast Cancer Pts Who Progress on Prior Trastuzumab & Taxane Tx
Phase: N/A
Priority: Normal
Start: 05/21/14
End: 05/20/17
Due: 05/20/18
Phase: N/A
Priority: Normal
Start: 09/01/22
End: 02/02/23
Due: 02/02/24
Phase: N/A
Priority: Normal
Start: 08/01/20
End: 03/26/24
Due: 03/26/25
Phase: N/A
Priority: Normal
Start: 02/10/17
End: 08/05/22
Due: 08/05/23
Phase: N/A
Priority: Normal
Start: 06/30/11
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/30/14
End: 09/21/21
Due: 09/21/22
Phase: N/A
Priority: Normal
Start: 10/07/19
End: 01/31/25
Due: 01/31/26
Phase: N/A
Priority: Normal
Start: 04/01/24
End: 08/01/28
Due: 08/01/29
Phase: N/A
Priority: Normal
Start: 08/31/11
End: 01/31/14
Due: 01/31/15
Phase: N/A
Priority: Normal
Start: 02/20/09
End: 01/31/22
Due: 01/31/23
Phase: N/A
Priority: Normal
Start: 01/31/12
End: 11/30/14
Due: 11/30/15
Phase: N/A
Priority: Normal
Start: 03/31/13
End: 07/31/20
Due: 07/31/21
Phase: N/A
Priority: Normal
Start: 03/31/12
End: 07/31/12
Due: 07/31/13
Phase: N/A
Priority: Normal
Start: 11/30/16
End: 10/31/21
Due: 10/31/22
Phase: N/A
Priority: Normal
Start: 07/11/23
End: 05/25/28
Due: 05/25/29
Phase: N/A
Priority: Normal
Start: 03/12/23
End: 11/30/24
Due: 11/30/25
Phase: N/A
Priority: Normal
Start: 04/03/25
End: 04/30/27
Due: 04/30/28
Phase: N/A
Priority: Normal
Start: 07/27/20
End: 12/31/20
Due: 12/31/21
Phase: N/A
Priority: Normal
Start: 01/31/10
End: 06/30/16
Due: 06/30/17
Phase: N/A
Priority: Normal
Start: 07/31/02
End: 08/31/04
Due: 08/31/05
Phase: N/A
Priority: Normal
Start: 09/19/16
End: 08/15/17
Due: 08/15/18